Skip to main content

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Mohler, JL; Antonarakis, ES; Armstrong, AJ; D'Amico, AV; Davis, BJ; Dorff, T; Eastham, JA; Enke, CA; Farrington, TA; Higano, CS; Horwitz, EM ...
Published in: J Natl Compr Canc Netw
May 1, 2019

The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer. The portions of the guidelines included herein focus on the roles of germline and somatic genetic testing, risk stratification with nomograms and tumor multigene molecular testing, androgen deprivation therapy, secondary hormonal therapy, chemotherapy, and immunotherapy in patients with prostate cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

May 1, 2019

Volume

17

Issue

5

Start / End Page

479 / 505

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Disease Susceptibility
  • Disease Management
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D’Amico, A. V., Davis, B. J., Dorff, T., … Freedman-Cass, D. A. (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(5), 479–505. https://doi.org/10.6004/jnccn.2019.0023
Mohler, James L., Emmanuel S. Antonarakis, Andrew J. Armstrong, Anthony V. D’Amico, Brian J. Davis, Tanya Dorff, James A. Eastham, et al. “Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 17, no. 5 (May 1, 2019): 479–505. https://doi.org/10.6004/jnccn.2019.0023.
Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T, et al. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 May 1;17(5):479–505.
Mohler, James L., et al. “Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 17, no. 5, May 2019, pp. 479–505. Pubmed, doi:10.6004/jnccn.2019.0023.
Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 May 1;17(5):479–505.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

May 1, 2019

Volume

17

Issue

5

Start / End Page

479 / 505

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Disease Susceptibility
  • Disease Management
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis